Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling

被引:125
作者
Tam, Joseph
Ofek, Orr
Fride, Ester
Ledent, Catherine
Gabet, Yankel
Mueller, Ralph
Zimmer, Andreas
Mackie, Ken
Mechoulam, Raphael
Shohami, Esther
Bab, Itai
机构
[1] Hebrew Univ Jerusalem, Bone Lab, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Dept Pharmacol, IL-91120 Jerusalem, Israel
[4] Hebrew Univ Jerusalem, Sch Pharm, David R Bloom Ctr Pharm, IL-91120 Jerusalem, Israel
[5] Coll Judea & Samaria, Dept Behav Sci, Ariel, Israel
[6] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Brussels, Belgium
[7] Univ Zurich, Zurich, Switzerland
[8] Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland
[9] Univ Bonn, Dept Psychiat, Mol Neurobiol Lab, D-5300 Bonn, Germany
[10] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA
[11] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA
关键词
D O I
10.1124/mol.106.026435
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The CB1 cannabinoid receptor has been implicated in the regulation of bone remodeling and bone mass. A high bone mass (HBM) phenotype was reported in CB1-null mice generated on a CD1 background (CD1(CB1-/-) mice). By contrast, our preliminary studies in cb1(-/-) mice, backcrossed to C57BL/6J mice (C57(CB1-/-) mice), revealed low bone mass (LBM). We therefore analyzed CB1 expression in bone and compared the skeletons of sexually mature C57(CB1-/-) and CD1(CB1-/-) mice in the same experimental setting. CB1 mRNA is weakly expressed in osteoclasts and immunoreactive CB1 is present in sympathetic neurons, close to osteoblasts. In addition to their LBM, male and female C57(CB1-/-) mice exhibit decreased bone formation rate and increased osteoclast number. The skeletal phenotype of the CD1(CB1-/-) mice shows a gender disparity. Female mice have normal trabecular bone with a slight cortical expansion, whereas male CD1(CB1-/-) animals display an HBM phenotype. We were surprised to find that bone formation and resorption are within normal limits. These findings, at least the consistent set of data obtained in the C57(CB1-/-) line, suggest an important role for CB1 signaling in the regulation of bone remodeling and bone mass. Because sympathetic CB1 signaling inhibits norepinephrine (NE) release in peripheral tissues, part of the endocannabinoid activity in bone may be attributed to the regulation of NE release from sympathetic nerve fibers. Several phenotypic discrepancies have been reported between C57(CB1-/-) and CD1(CB1-/-) mice that could result from genetic differences between the background strains. Unraveling these differences can provide useful information on the physiologic functional milieu of CB1 in bone.
引用
收藏
页码:786 / 792
页数:7
相关论文
共 23 条
[1]   Central IL-1 receptor signaling regulates bone growth and mass [J].
Bajayo, A ;
Goshen, I ;
Feldman, S ;
Csernus, V ;
Iverfeldt, K ;
Shohami, E ;
Yirmiya, R ;
Bab, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (36) :12956-12961
[2]   Hypothalamic Y2 receptors regulate bone formation [J].
Baldock, PA ;
Sainsbury, A ;
Couzens, M ;
Enriquez, RF ;
Thomas, GP ;
Gardiner, EM ;
Herzog, H .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (07) :915-921
[3]   NEUROPEPTIDE Y-IMMUNOREACTIVE, TYROSINE HYDROXYLASE-IMMUNOREACTIVE AND VASOACTIVE INTESTINAL POLYPEPTIDE-IMMUNOREACTIVE NERVES IN BONE AND SURROUNDING TISSUES [J].
BJURHOLM, A ;
KREICBERGS, A ;
TERENIUS, L ;
GOLDSTEIN, M ;
SCHULTZBERG, M .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1988, 25 (2-3) :119-125
[4]   Leptin-regulated endocannabinoids are involved in maintaining food intake [J].
Di Marzo, V ;
Goparaju, SK ;
Wang, L ;
Liu, J ;
Bátkai, S ;
Járai, Z ;
Fezza, F ;
Miura, GI ;
Palmiter, RD ;
Sugiura, T ;
Kunos, G .
NATURE, 2001, 410 (6830) :822-825
[5]   Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass [J].
Ducy, P ;
Amling, M ;
Takeda, S ;
Priemel, M ;
Schilling, AF ;
Beil, FT ;
Shen, JH ;
Vinson, C ;
Rueger, JM ;
Karsenty, G .
CELL, 2000, 100 (02) :197-207
[6]   Leptin regulation of bone resorption by the sympathetic nervous system and CART [J].
Elefteriou, F ;
Ahn, JD ;
Takeda, S ;
Starbuck, M ;
Yang, XL ;
Liu, XY ;
Kondo, H ;
Richards, WG ;
Bannon, TW ;
Noda, M ;
Clement, K ;
Vaisse, C ;
Karsenty, G .
NATURE, 2005, 434 (7032) :514-520
[7]   CANNABINOID RECEPTOR LOCALIZATION IN BRAIN [J].
HERKENHAM, M ;
LYNN, AB ;
LITTLE, MD ;
JOHNSON, MR ;
MELVIN, LS ;
DECOSTA, BR ;
RICE, KC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1932-1936
[8]   Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus [J].
Hoffman, AF ;
Macgill, AM ;
Smith, D ;
Oz, M ;
Lupica, CR .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (09) :2387-2391
[9]   Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors [J].
Idris, AI ;
Hof, RJV ;
Greig, IR ;
Ridge, SA ;
Baker, D ;
Ross, RA ;
Ralston, SH .
NATURE MEDICINE, 2005, 11 (07) :774-779
[10]   Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves [J].
Ishac, EJN ;
Jiang, L ;
Lake, KD ;
Varga, K ;
Abood, ME ;
Kunos, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (08) :2023-2028